Corcept Therapeutics
CORT
#1699
Rank
NZ$16.88 B
Marketcap
$160.08
Share price
-19.51%
Change (1 day)
270.18%
Change (1 year)

Corcept Therapeutics (CORT) - P/B ratio

P/B ratio as of April 2025 : 14.3

According to Corcept Therapeutics 's latest financial reports the company has a price-to-book ratio of 14.3679.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Corcept Therapeutics - P/B ratio (from 2004 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-318.0922.43%
2023-12-316.6151.66%
2022-12-314.36-28.38%
2021-12-316.084.75%
2020-12-315.8155.51%
2019-12-313.73-32.97%
2018-12-315.57-48.39%
2017-12-3110.8-44.6%
2016-12-3119.5-34%
2015-12-3129.5-132.88%
2014-12-31-89.8-688.73%
2013-12-3115.3560.05%
2012-12-312.31-72.08%
2011-12-318.28-37.09%
2010-12-3113.267.34%
2009-12-317.86161.86%
2008-12-313.00-63.8%
2007-12-318.2966.66%
2006-12-314.9860.13%
2005-12-313.110.9%
2004-12-313.08
2003-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
5.17-63.80%๐Ÿ‡บ๐Ÿ‡ธ USA
7.39-48.19%๐Ÿ‡บ๐Ÿ‡ธ USA
4.98-65.08%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
50.7 255.01%๐Ÿ‡บ๐Ÿ‡ธ USA
1.57-88.98%๐Ÿ‡บ๐Ÿ‡ธ USA
4.75-66.75%๐Ÿ‡บ๐Ÿ‡ธ USA
-0.7177-105.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-19.1-233.60%๐Ÿ‡บ๐Ÿ‡ธ USA
2.29-83.95%๐Ÿ‡บ๐Ÿ‡ธ USA